AR026424A1 - Soluciones que contienen epinastina - Google Patents
Soluciones que contienen epinastinaInfo
- Publication number
- AR026424A1 AR026424A1 ARP000105932A ARP000105932A AR026424A1 AR 026424 A1 AR026424 A1 AR 026424A1 AR P000105932 A ARP000105932 A AR P000105932A AR P000105932 A ARP000105932 A AR P000105932A AR 026424 A1 AR026424 A1 AR 026424A1
- Authority
- AR
- Argentina
- Prior art keywords
- solutions containing
- containing epinastine
- possibly
- epinastine
- spinastine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Suspension/Interruption
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
- F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
- F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
- F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T137/00—Fluid handling
- Y10T137/0318—Processes
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- General Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Detergent Compositions (AREA)
Abstract
La presente se refiere a soluciones acuosas aplicables por vía topica que contienen espinastina, eventualmente en forma de sus racematos, sus enantiomeros,así como eventualmente en forma de sus sales por adicion de ácidos farmacologicamente inocuas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19954516A DE19954516A1 (de) | 1999-11-12 | 1999-11-12 | Epinastin-haltige Lösungen |
Publications (1)
Publication Number | Publication Date |
---|---|
AR026424A1 true AR026424A1 (es) | 2003-02-12 |
Family
ID=7928843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000105932A Suspension/Interruption AR026424A1 (es) | 1999-11-12 | 2000-11-10 | Soluciones que contienen epinastina |
Country Status (40)
Country | Link |
---|---|
US (6) | US20030050303A1 (es) |
EP (1) | EP1231920B1 (es) |
JP (1) | JP2003514021A (es) |
KR (1) | KR100758842B1 (es) |
CN (1) | CN1292752C (es) |
AR (1) | AR026424A1 (es) |
AT (1) | ATE353218T1 (es) |
AU (2) | AU784017B2 (es) |
BG (1) | BG65775B1 (es) |
BR (1) | BR0015477A (es) |
CA (1) | CA2391076C (es) |
CO (1) | CO5251448A1 (es) |
CY (1) | CY1106375T1 (es) |
CZ (1) | CZ302483B6 (es) |
DE (2) | DE19954516A1 (es) |
DK (1) | DK1231920T3 (es) |
EA (1) | EA006937B1 (es) |
EE (1) | EE05395B1 (es) |
ES (1) | ES2281359T3 (es) |
HK (1) | HK1052303B (es) |
HR (1) | HRP20020404B1 (es) |
HU (1) | HU229502B1 (es) |
IL (2) | IL149501A0 (es) |
ME (1) | MEP36708A (es) |
MX (1) | MXPA02004556A (es) |
MY (1) | MY130441A (es) |
NO (1) | NO329417B1 (es) |
NZ (1) | NZ519425A (es) |
PE (1) | PE20010826A1 (es) |
PL (1) | PL198879B1 (es) |
PT (1) | PT1231920E (es) |
RS (1) | RS50173B (es) |
SA (1) | SA01210658B1 (es) |
SI (1) | SI1231920T1 (es) |
SK (1) | SK287343B6 (es) |
TR (1) | TR200201270T2 (es) |
TW (1) | TWI225401B (es) |
UA (1) | UA74563C2 (es) |
WO (1) | WO2001035962A1 (es) |
ZA (1) | ZA200203683B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19954516A1 (de) * | 1999-11-12 | 2001-05-17 | Boehringer Ingelheim Int | Epinastin-haltige Lösungen |
WO2004014353A1 (en) * | 2002-08-02 | 2004-02-19 | Boehringer Ingelheim International Gmbh | Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine |
US20040247686A1 (en) * | 2003-04-04 | 2004-12-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions comprising epinastine for the treatment of skin diseases |
EP1468696A1 (en) * | 2003-04-17 | 2004-10-20 | Boehringer Ingelheim International GmbH | Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases |
US20060073172A1 (en) * | 2004-10-01 | 2006-04-06 | Schneider L W | Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure |
KR20080034916A (ko) * | 2005-07-08 | 2008-04-22 | 센주 세이야꾸 가부시키가이샤 | 에피나스틴을 포함하는 경피 흡수 안과 제제 |
US20080194544A1 (en) * | 2007-02-08 | 2008-08-14 | Ramesh Krishnamoorthy | Aqueous formulations of epinastine for treating allergic rhinitis |
WO2008098122A2 (en) * | 2007-02-08 | 2008-08-14 | Inspire Pharmaceuticals, Inc. | Method for treating allergic rhinitis without adverse effects |
US7378082B1 (en) | 2007-11-05 | 2008-05-27 | Inspire Pharmaceuticals, Inc. | Method for treating allergic rhinitis without adverse effects |
EP2464387A4 (en) * | 2009-08-12 | 2013-05-15 | Seros Medical Llc | DEUTERATED WATER SOLUTION AND RIBOFLAVIN FOR EXTENDED OXYGEN SINGULET LIFETIME IN THE TREATMENT OF OCULAR TISSUE AND METHOD OF USE |
TWI544922B (zh) | 2011-05-19 | 2016-08-11 | 愛爾康研究有限公司 | 高濃度歐羅派特錠(olopatadine)眼用組成物 |
EP2630952A1 (en) * | 2012-02-23 | 2013-08-28 | Novagali Pharma S.A. | Self-preserved oil dispersions comprising boric acid |
DK2934510T3 (da) * | 2012-12-19 | 2021-01-25 | Novartis Ag | Lfa-1-inhibitorformuleringer |
CN104491876A (zh) * | 2014-12-23 | 2015-04-08 | 中国药科大学 | 含玻璃酸钠的依匹斯汀滴眼液及其制备方法 |
ITUB20153950A1 (it) * | 2015-09-28 | 2017-03-28 | Tred Srl | Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea |
JP6134853B1 (ja) * | 2016-10-28 | 2017-05-24 | 参天製薬株式会社 | エピナスチン含有点眼液 |
JP6635974B2 (ja) * | 2017-04-24 | 2020-01-29 | 参天製薬株式会社 | エピナスチン含有点眼液 |
KR102582048B1 (ko) * | 2017-05-01 | 2023-09-21 | 산텐 세이야꾸 가부시키가이샤 | 점안제 |
JP2019108320A (ja) * | 2018-10-31 | 2019-07-04 | 参天製薬株式会社 | ソフトコンタクトレンズの変質を抑制する眼科用組成物 |
JP6736752B2 (ja) * | 2019-12-17 | 2020-08-05 | 参天製薬株式会社 | エピナスチン含有点眼液 |
JP6963651B2 (ja) * | 2020-04-16 | 2021-11-10 | 参天製薬株式会社 | エピナスチン又はその塩を含有する水性組成物 |
JP7118579B1 (ja) | 2020-04-16 | 2022-08-16 | 参天製薬株式会社 | エピナスチン又はその塩を含有する水性組成物 |
JP2020169213A (ja) * | 2020-07-15 | 2020-10-15 | 参天製薬株式会社 | エピナスチン含有点眼液 |
CN115448927A (zh) * | 2022-10-20 | 2022-12-09 | 重庆瑞泊莱医药科技有限公司 | 一种氢溴酸依匹斯汀晶型ii及其制备方法 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US151541A (en) * | 1874-06-02 | Improvement in hay-loaders | ||
US8632A (en) * | 1852-01-06 | George hess | ||
US104017A (en) * | 1870-06-07 | Improvement in embroidering attachment for sewing-machines | ||
US203021A (en) * | 1878-04-30 | Improvement in side-bar wagons | ||
US228359A (en) * | 1880-06-01 | jones | ||
US215396A (en) * | 1879-05-13 | Improvement in loom-temples | ||
US181478A (en) * | 1876-08-22 | Improvement in water-wheels | ||
DE3008944A1 (de) * | 1980-03-08 | 1981-09-24 | C.H. Boehringer Sohn, 6507 Ingelheim | Dibenzimidazoazepine, ihre herstellung und verwendung |
DE4102148A1 (de) * | 1991-01-25 | 1992-07-30 | Boehringer Ingelheim Kg | Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid |
US5668133A (en) * | 1992-12-09 | 1997-09-16 | Alcon Laboratories, Inc. | Ophthalmic compositions comprising emedastine and methods for their use |
EE03509B2 (et) * | 1995-06-27 | 2015-02-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Stabiilsed ravimikompositsioonid kandegaasita aerosoolide saamiseks |
DE19542281C2 (de) * | 1995-11-14 | 1997-12-04 | Boehringer Ingelheim Kg | Verwendung von Epinastin für die Behandlung der Migräne |
AU3869197A (en) * | 1996-08-30 | 1998-03-19 | Kyoto Pharmaceutical Industries, Ltd. | Remedies for allergic dermatitis |
DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
US20030215396A1 (en) * | 1999-09-15 | 2003-11-20 | Boehringer Ingelheim Pharma Kg | Method for the production of propellant gas-free aerosols from aqueous medicament preparations |
EP0903151A1 (en) * | 1997-09-22 | 1999-03-24 | ASTA Medica Aktiengesellschaft | Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
DE19954516A1 (de) * | 1999-11-12 | 2001-05-17 | Boehringer Ingelheim Int | Epinastin-haltige Lösungen |
CN1376066A (zh) * | 1999-11-18 | 2002-10-23 | 爱尔康公司 | H1拮抗剂和安全类固醇的治疗眼病的用途 |
DE19958460A1 (de) * | 1999-12-03 | 2001-06-07 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation |
FR2803520B1 (fr) * | 2000-01-12 | 2002-09-20 | Ceva Sante Animale | Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles |
US20020094345A1 (en) * | 2000-10-06 | 2002-07-18 | Sara Abelaira | Pharmaceutical compositions containing epinastine and pseudoephedrine |
US20020151541A1 (en) * | 2000-10-31 | 2002-10-17 | Michel Pairet | Pharmaceutical compositions containing tiotropium salts and antihistamines and their use |
US20020137764A1 (en) * | 2000-10-31 | 2002-09-26 | Karin Drechsel | Inhalable formulation of a solution containing a tiotropium salt |
DE10119718A1 (de) * | 2001-04-21 | 2002-10-31 | Boehringer Ingelheim Pharma | Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff |
WO2002098112A2 (en) * | 2001-05-29 | 2002-12-05 | Transchip, Inc. | Patent application cmos imager for cellular applications and methods of using such |
US20030104017A1 (en) * | 2001-10-26 | 2003-06-05 | Boehringer Ingelheim International Gmbh | Epinastine formulation for oral administration |
EP1350512A1 (en) * | 2002-04-03 | 2003-10-08 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations |
US6863848B2 (en) * | 2002-08-30 | 2005-03-08 | Signet Armorlite, Inc. | Methods for preparing composite photochromic ophthalmic lenses |
JP2007145316A (ja) * | 2005-10-27 | 2007-06-14 | Nissan Motor Co Ltd | 遮光装置とサンバイザーとサンルーフユニット |
-
1999
- 1999-11-12 DE DE19954516A patent/DE19954516A1/de not_active Withdrawn
-
2000
- 2000-10-14 MX MXPA02004556A patent/MXPA02004556A/es active IP Right Grant
- 2000-10-14 SI SI200030938T patent/SI1231920T1/sl unknown
- 2000-10-14 JP JP2001537955A patent/JP2003514021A/ja active Pending
- 2000-10-14 UA UA2002064760A patent/UA74563C2/uk unknown
- 2000-10-14 BR BR0015477-6A patent/BR0015477A/pt not_active Application Discontinuation
- 2000-10-14 IL IL14950100A patent/IL149501A0/xx unknown
- 2000-10-14 EE EEP200200246A patent/EE05395B1/xx unknown
- 2000-10-14 AU AU11381/01A patent/AU784017B2/en not_active Expired
- 2000-10-14 PL PL364028A patent/PL198879B1/pl unknown
- 2000-10-14 PT PT00972763T patent/PT1231920E/pt unknown
- 2000-10-14 EP EP00972763A patent/EP1231920B1/de not_active Expired - Lifetime
- 2000-10-14 AT AT00972763T patent/ATE353218T1/de active
- 2000-10-14 ES ES00972763T patent/ES2281359T3/es not_active Expired - Lifetime
- 2000-10-14 WO PCT/EP2000/010122 patent/WO2001035962A1/de active IP Right Grant
- 2000-10-14 CN CNB00815547XA patent/CN1292752C/zh not_active Expired - Lifetime
- 2000-10-14 RS YUP-336/02A patent/RS50173B/sr unknown
- 2000-10-14 EA EA200200492A patent/EA006937B1/ru not_active IP Right Cessation
- 2000-10-14 ME MEP-367/08A patent/MEP36708A/xx unknown
- 2000-10-14 CA CA002391076A patent/CA2391076C/en not_active Expired - Lifetime
- 2000-10-14 NZ NZ519425A patent/NZ519425A/en not_active IP Right Cessation
- 2000-10-14 DK DK00972763T patent/DK1231920T3/da active
- 2000-10-14 DE DE50014041T patent/DE50014041D1/de not_active Expired - Lifetime
- 2000-10-14 HU HU0203773A patent/HU229502B1/hu unknown
- 2000-10-14 SK SK830-2002A patent/SK287343B6/sk not_active IP Right Cessation
- 2000-10-14 KR KR1020027006058A patent/KR100758842B1/ko active IP Right Grant
- 2000-10-14 CZ CZ20021956A patent/CZ302483B6/cs not_active IP Right Cessation
- 2000-10-14 TR TR2002/01270T patent/TR200201270T2/xx unknown
- 2000-11-10 TW TW089123815A patent/TWI225401B/zh not_active IP Right Cessation
- 2000-11-10 AR ARP000105932A patent/AR026424A1/es not_active Suspension/Interruption
- 2000-11-10 MY MYPI20005284A patent/MY130441A/en unknown
- 2000-11-10 PE PE2000001201A patent/PE20010826A1/es not_active Application Discontinuation
- 2000-11-10 CO CO00085787A patent/CO5251448A1/es not_active Application Discontinuation
-
2001
- 2001-01-20 SA SA01210658A patent/SA01210658B1/ar unknown
-
2002
- 2002-05-07 IL IL149501A patent/IL149501A/en active IP Right Grant
- 2002-05-08 NO NO20022201A patent/NO329417B1/no not_active IP Right Cessation
- 2002-05-09 HR HR20020404A patent/HRP20020404B1/xx not_active IP Right Cessation
- 2002-05-09 ZA ZA200203683A patent/ZA200203683B/xx unknown
- 2002-05-09 BG BG106681A patent/BG65775B1/bg unknown
- 2002-10-15 US US10/271,180 patent/US20030050303A1/en not_active Abandoned
-
2003
- 2003-06-30 HK HK03104651.9A patent/HK1052303B/zh not_active IP Right Cessation
-
2005
- 2005-08-30 US US11/215,165 patent/US20050288274A1/en not_active Abandoned
-
2006
- 2006-04-12 AU AU2006201541A patent/AU2006201541A1/en not_active Abandoned
-
2007
- 2007-03-13 CY CY20071100351T patent/CY1106375T1/el unknown
- 2007-04-12 US US11/734,512 patent/US20070185082A1/en not_active Abandoned
- 2007-04-12 US US11/734,507 patent/US20070197503A1/en not_active Abandoned
- 2007-09-27 US US11/863,008 patent/US7429602B2/en not_active Expired - Lifetime
-
2009
- 2009-02-27 US US12/394,684 patent/US20090239842A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR026424A1 (es) | Soluciones que contienen epinastina | |
CO4520208A1 (es) | Estabilizador para perforacion direccional | |
AR056367A1 (es) | Uso de soluciones blanqueadoras | |
ECSP034460A (es) | Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos | |
GT199900055A (es) | Nuevas dihidropirimidinas2 heterocìclicamente sustituidas. | |
UY26841A1 (es) | Sales estables de ácido o-acetilsalicílico con aminoácidos básicos | |
UY28069A1 (es) | Nuevos derivados de xantina, su preparación y su uso como medicamento | |
AR026433A1 (es) | Variantes de alfa-amilasa tipo fungamyl | |
BR9911431A (pt) | Processo para produção de uma solução aquosa de ácido monoéster peroxicarboxìlico | |
ES2192183T3 (es) | Derivados de imidazopiridina como inhibidores de fosfodiesterasa vii. | |
BRPI0108990B8 (pt) | processo para preparação de derivados de pirimidona com atividade antifungos | |
UY32001A (es) | Nitratos de isosorbida | |
PA8644201A1 (es) | Hexadecasacaridos biotinilados, su preparacion y utilizacion | |
BR0210664A (pt) | Processo de sìntese técnico para produção de tropenol | |
BR0115139A (pt) | Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante | |
BRPI0415034A (pt) | derivados de aminopiridina como inibidores de não-sintase induzìveis | |
BRPI0512701A (pt) | sais fundidos, método de sua produção e processo para geração de peróxido de hidrogênio | |
UY27612A1 (es) | Sales estables del ácido o-acetilsalicílico con aminoácidos básicos l l | |
ECSP003758A (es) | Soluciones que contienen epinastina | |
AR063597A1 (es) | Nueva sal | |
UY26432A1 (es) | Soluciones que contienen epinastina | |
AR031175A1 (es) | Decoloracion del guarapo por medio de intercambiadores de aniones monodispersados | |
SV2002000302A (es) | Nuevos derivados de amidas heterociclicas ref. pc 10561/20140/bb | |
HN2000000090A (es) | Sal difosfato de un derivado de 4sustituido-9-desoxo-9a-aza-9a-homoeritromicina y su composicion farmaceutica. | |
AR078093A1 (es) | Oligosacaridos n- sulfatados activadores de los receptores de los fgf, su preparacion y su aplicacion en terapeutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |